This year has brought good tidings to the S&P/ASX 200 Index (ASX: XJO) and these five shares are among those making the most of it.
They've each jumped as much as 5.8% to reach their highest point in more than a year on Tuesday.
Meanwhile, the iconic index is up 0.44% at 7,490.4 points at the time of writing. That's 7.8% higher than it was at the start of the year.
Let's take a closer look at what's sent these market giants soaring today.
Image source: Getty Images
These ASX 200 shares are roaring to long-forgotten heights
The first ASX 200 share posting a new 52-week high is Clinuvel Pharmaceuticals Limited (ASX: CUV). Stock in the biopharmaceutical developer lifted 2.6% to reach $27.42 earlier today – the highest it's been since 2021.
It follows yesterday's news of the company's analogue adrenocorticotropic hormone (ACTH). It's aiming to submit a regulatory drug master file for the product in the second half of this year – an "aggressive goal" according to chief scientific officer Dr Dennis Wright.
The Mineral Resources Ltd (ASX: MIN) share price is also rocketing on Tuesday, hitting a new record high amid a broker upgrade. The stock peaked at $96.78 earlier today – a 5.8% gain.
UBS has reportedly upped its expectations for lithium. It now tips demand to outweigh supply in the near and medium term, the Australian Financial Review reports.
In response, it's slapped a buy rating on shares in the ASX 200 materials giant.
Meanwhile, the TechnologyOne Ltd (ASX: TNE) share price is in the green for a third consecutive day. It follows the release of the company's non-price-sensitive annual report on Thursday evening.
The tech stock reached an all-time high of $14.705 today – marking a 2% rise.
ASX 200 travel giant Webjet Limited (ASX: WEB), on the other hand, popped then dropped today, hitting a post-pandemic high of $6.86 this morning before plunging into the red.
Today's peak saw the stock 1.2% higher than its previous close and around 170% higher than its 2020 low.
Finally, shares in ASX 200 health imaging technology provider Pro Medicus Limited (ASX: PME) have continued to inch towards their all-time high today.
The stock has posted a new 52-week high for a third consecutive session. This time it peaked at $64.77 – a 2.4% jump.
Its gains might be a belated reaction to Friday's announcement, detailing a $25 million contract with the University of Washington.
